在复发性头癌中,新的多剂量水平避免再辐射技术方法的可行性和灵活性
Thomas Hague1, Rikki Lad1, Kevin Chiu2
1Department of Radiotherapy, Mount Vernon Cancer Centre, Northwood HA6 2RN, United Kingdom.
BJR case reports
|July 10, 2024
概括
对复发性头癌的再辐射在技术上是可行的,但需要仔细的患者选择和复杂的治疗计划. 本技术说明详细介绍了成功的多剂量再辐射策略,用于头癌患者.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
背景情况:
- 复发性头癌的再辐射带来了重大的临床和技术挑战.
- 先进的治疗规划和输送技术对于管理先前治疗中的重叠辐射剂量至关重要.
研究的目的:
- 描述复发性头癌多剂量水平再辐射的技术规划方法.
- 提出临床案例研究,说明复杂的重叠治疗体积在再辐射的方法.
主要方法:
- 详细描述了治疗计划方法对三个复发头癌病例的详细描述.
- 从初始放射治疗来管理复杂的重叠剂量分布的技术的规范.
主要成果:
- 成功地规划和执行了三名患有复发性状细胞癌的患者的多剂量水平再辐射.
- 对复杂的再辐射治疗计划的可行方法的演示.
结论:
- 对复发的头癌的再辐射在技术上是可以实现的,只要有先进的计划.
- 仔细的患者选择和对剂量重叠的仔细注意对于成功的再照射结果至关重要.
更多相关视频
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


